BioElectronics

The BioElectronics R&D team is seeking a physician or clinical researcher who is interested in collaborating on a vulvodynia-focused study to evaluate the effectiveness of RecoveryRx for treating vulvodynia pain.

RecoveryRx is a class II, USA FDA-cleared, drug-free, non-invasive, disposable, non-thermal shortwave therapy device that utilizes radio-frequency electromagnetic energy to modulate nerve activity. When used adjunctively, RecoveryRx has been found to reduce pain and the consumption of pain medication, including opioids. Our current published clinical data can be viewed at www.bielcorp.com

We’re working on a grant proposal for the National Vulvodynia Association and seek to partner with a medical professional who is excited about turning good clinical ideas into real-world evidence. This is an early-stage collaboration meaning no finalized protocol, no overwhelming paperwork (yet!), and no heavy upfront commitment. Just shared interest, clinical insight, and a desire to improve care for patients who truly need better options.

Please contact us at 301.874.4890 or email us at [email protected]

🍁 Happy Thanksgiving from BioElectronics Corporation! 🦃

As we gather for the holiday, we want to extend our heartfelt gratitude to everyone who makes our mission possible.
To our shareholders, thank you for believing in our vision.
To our vendors and partners, thank you for your collaboration and commitment.
And to our customers, thank you for trusting our technologies to help support healthier, more comfortable lives.

We are truly thankful for your continued support and look forward to an exciting year ahead.
Wishing you and your families a warm, joyful, and pain-free Thanksgiving holiday! 🍂 Our offices will reopen on Monday, December 1st.